Surgery Websites
Cardiothoracic Surgery »  Team »  Interim Division Chief »  Michael S. Conte, M.D.

Michael S. Conte, MD

  • Interim Chief, Division of Cardiothoracic Surgery
  • Professor & Chief, Division of Vascular and Endovascular Surgery
  • Edwin J. Wylie, M.D. Chair in Vascular Surgery
  • Co-Director, UCSF Heart and Vascular Center
  • Co-Director, UCSF Center for Limb Preservation
  • Director, Vascular Surgery Fellowship & Integrated Residency Programs

Contact Information

Division of Vascular and Endovascular Surgery
400 Parnassus Avenue, A-501
San Francisco, CA 94143-0957
Phone: (415) 353-2357
Fax: (415) 353-2669
[email protected]
Open Popup
  • 1978-82, Boston University, B.S., Biomedical Engineering
  • 1982-86, Albert Einstein College of Medicine, M.D., Medicine
  • 1986-88, New York Hospital, Cornell Medical Center, Junior Resident, General Surgery
  • 1988-89, New York Hospital, Cornell Medical Center, Senior Resident, General Surgery
  • 1991-92, New York Hospital, Cornell Medical Center, Senior Resident, General Surgery
  • 1992-93, New York Hospital, Cornell Medical Center, Chief Resident, General Surgery
  • 1989-91, Brigham and Women's Hospital/Harvard, Research Fellow, Vascular Surgery
  • 1993-94, Harvard Medical School, Fellow, Vascular Surgery
  • 1993-94, Brigham and Women's Hospital, Fellow, Vascular Surgery
  • American Board of Surgery, General Surgery, 1994
  • American Board of Surgery, Vascular Surgery, 1996
  • Cardiovascular Research Institute (CVRI)
  • UCSF Heart and Vascular Center
  • Abdominal Aortic Aneurysm
  • Carotid Artery Disease
  • Complex Limb Revascularization
  • Critical Limb Ischemia
  • Diabetic Vascular Disease
  • Dialysis Access
  • Endovascular Aneurysm Repair
  • Mesenteric Artery Disease
  • Peripheral Artery Disease
  • Thoracic Aortic Aneurysm
  • Thoracic Outlet Syndrome

Dr. Michael Conte received his medical degree in 1986 at Albert Einstein College of Medicine. He completed his surgical residency at New York Hospital-Cornell Medical Center in 1993, which included a two year research fellowship at Brigham and Women's Hospital (BWH) and Massachusetts Institute of Technology in Boston. He completed his vascular surgery training in 1994 as the John Homans Fellow at BWH and Harvard Medical School (HMS), in Boston.

Dr. Conte was an Assistant Professor of Surgery at Yale University from 1994-1997, and a member of the Boyer Center for Molecular Medicine. Subsequently he returned to BWH where he served as Assistant Professor (1997-2001) and then Associate Professor (2001-2008 ) of Surgery at HMS. From 2002-2008, he was the Director of Vascular Surgical Research at BWH and from 2005-2008, he was Co-Director of the Clinical Trials Group at the Center for Surgery and Public Health (a joint initiative between HMS, BWH, and the Harvard School for Public Health).

Dr. Conte is a member of many professional organizations, including the Society for Vascular Surgery and the Society of University Surgeons. Dr. Conte has also been an invited lecturer for many regional, national, and international meetings and conferences. In 2006, he received the Distinguished Achievement Award from the New York Weill Cornell Medical Center Alumni Council. He is on the Editorial Board for Vascular and Endovascular Surgery, Vascular Medicine, Journal of Vascular Surgery, and Vascular. He has served as an Associate Editor for Circulation.

In 2017, Dr. Conte was named to Castle Connolly's list of the "Bay Area Top Doctors 2017" for Vascular Surgery.

  Confired By    
  • Peripheral Vascular Disease Distinguished Achievement Award
  • American Heart Association
  • 2019
  • Bay Area Top Doctors
  • San Francisco Magazine
  • 2016
  • Best Doctors in America
  • Best Doctors, Inc.
  • 2015
  • T1 Catalyst Award Finalist
  • UCSF Clinical and Translational Sciences Institute (CTSI)
  • 2012
  • Best Doctors in America
  • Best Doctors, Inc.
  • 2009
  • Best Doctors in Boston
  • Best Doctors, Inc.
  • 2007
  • Distinguished Achievement Award
  • New York Weill Cornell Medical Center Alumni Council
  • 2006
  • Mentored Clinical Scientist Development Award
  • NHLBI/Lifeline
  • 1999
  • Fellowship Award
  • American Surgical Association Foundation
  • 1997 - 1999
  • Research Award
  • Lifeline Foundation
  • 1988
  • Alpha Omega Alpha
  • Medical Honor Society
  • 1986
  • Tau Beta Pi
  • National Engineering Honor Society
  • 1982
  • Dr. Conte's clinical interests include diseases of the aorta and its major branches, aneurysms, carotid artery disease, and peripheral artery disease (PAD). He is particularly interested in diabetic vascular disease, and in complex revascularization to preserve limb function and prevent amputation in patients with advanced forms of PAD. He had led the largest multicenter clinical trial to date examining the outcomes of leg bypass surgery in patients with severe PAD and is nationally and internationally recognized for his leadership in this area.

    Dr. Conte's research is focused on developing new molecular therapies to improve the long-term results of cardiovascular procedures. His translational research program includes basic laboratory investigations as well as prospective clinical trials to study the causes of failure of angioplasty and bypass surgery and develop new approaches to stratify patients at risk.

    Data provided by UCSF Profiles, powered by CTSI
    • UCSF Diabetic Foot Clinical Research Unit
      Sponsor ID:
      Funding Period:
      Sep 2018
      Jun 2022
      Principal Investigator
    • Tissue Oxygen Monitoring in Peripheral Vascular Disease
      Sponsor ID:
      Funding Period:
      Apr 2016
      Jul 2020
      Co-Principal Investigator
    • Specialized lipid mediators and mechanisms of resolution in vascular injury
      Sponsor ID:
      Funding Period:
      Aug 2013
      May 2017
      Principal Investigator
      Funding Period:
      Nov 2013
      Nov 2014
      Principal Investigator
    • Survivin: a novel regulator of intimal hyperplasia and vein graft remodeling
      Sponsor ID:
      Funding Period:
      Aug 2007
      Jun 2013
      Principal Investigator
    • General Clinical Research Center
      Sponsor ID:
      Funding Period:
      Dec 1984
      Mar 2010
      Sponsor ID:
      Funding Period:
      Sep 1999
      Aug 2004
      Principal Investigator
    Data provided by UCSF Profiles, powered by CTSI
    Data provided by UCSF Profiles, powered by CTSI
    1. Giles KA, Farber A, Menard MT, Conte MS, Nolan BW, Siracuse JJ, Strong M, Doros G, Venermo M, Azene E, Rosenfield K, Powell RJ. Surgery or Endovascular Therapy for Patients with Chronic Limb-threatening Ischemia Requiring Infrapopliteal Interventions. J Vasc Surg. 2024 Jun 20. View in PubMed
    2. Bose S, Dun C, Solomon AJ, Black JH, Conte MS, Kalbaugh CA, Woo K, Makary MA, Hicks CW. Infrapopliteal Peripheral Vascular Interventions for Claudication are Performed Frequently in the USA and Are Associated with Poor Long Term Outcomes. Eur J Vasc Endovasc Surg. 2024 Jun 19. View in PubMed
    3. Bose S, McDermott KM, Dun C, Mao J, Solomon AJ, Black JH, Columbo JA, Conte MS, Deery SE, Goodney PP, Kalathiya R, Kalbaugh CA, Siracuse JJ, Woo K, Makary MA, Hicks CW. Infrapopliteal Endovascular Interventions for Claudication Are Associated with Poor Long-Term Outcomes in Medicare-Matched Registry Patients. Ann Surg. 2024 Jun 06. View in PubMed
    4. Zarrintan S, Rahgozar S, Ross EG, Farber A, Menard MT, Conte MS, Malas MB. Endovascular therapy versus bypass for chronic limb-threatening ischemia in a real-world practice. J Vasc Surg. 2024 May 06. View in PubMed
    5. Streifel AC, Rivera Sarti JE, Sikka MK, Conte M, Winders B, Varley CD. Fixing a Hole: a retrospective cohort study evaluating HAV, HBV, tetanus screening, and vaccination during hospitalization in persons who use substances. Ther Adv Infect Dis. 2024 Jan-Dec; 11:20499361241245822. View in PubMed
    6. View All Publications
    Data provided by UCSF Profiles, powered by CTSI


    Site Directory